Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie 28. Novembre 2025
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Pancréas
Néoplasie
Pancréatite
Autres
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 2914  Page précédente Page suivante
   
   Articles 1 - 20 / 58267  
   
Actionable mutations in pancreatic cancer: where targeted therapies are making a difference.
BMJ Open Gastroenterol
Fivaz M, Bornand A, Corro C, Koessler T, Genoud V.
PMID: 41309265 [PubMed - indexed for MEDLINE]


Tumor-infiltrating lymphocyte aggregation refines prognosis in patients with hepatocellular carcinoma.
Lab Invest
Zhang Z, Lian Y, Wu Y, Weng Z, Ye J, Zhang S, Li L, Bai Y.
PMID: 41308747 [PubMed - as supplied by publisher]


Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study.
Lancet Oncol
Qin S, Gu S, Chan SL, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Xu L, Yuan X, Li D, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Du J, Shi W, Cheng AL, Kaseb A, Vogel A, CARES-310 Study Group.
PMID: 41308676 [PubMed - indexed for MEDLINE]


Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy.
Int J Nanomedicine
Lei SY, Qin H, Liu S, Sheng J.
PMID: 41306662 [PubMed - indexed for MEDLINE]


Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024).
J Clin Transl Hepatol
Zhao S, Li J, Liu L, Huang S, Gao Y, Liu M, Chen Y, Wei L, Jia J, You H, Duan Z, Zhuang H, Liu J, Xu X, Nan Y, Chinese Society of Hepatology, Chinese Medical Association.
PMID: 41306369 [PubMed]


The effect of circulating CD4+ and CD8+ T cells on the prognosis in advanced postoperative pancreatic adenocarcinoma patients who received chemotherapy.
Medicine (Baltimore)
Chang Q, Fan H, Si W, Mao J.
PMID: 41305823 [PubMed - indexed for MEDLINE]


Histopathological Scoring of Renal Injury in an Experimental Model of Acute Pancreatitis Caused by Karwinskia humboldtiana Fruit: Exploring Its Potential Utility in the Treatment of Pancreatic Cancer.
Pharmaceuticals (Basel)
Esparza-Rodríguez N, Solís-Flores NJ, Medellín-Zapata GG, Segoviano-Ramírez JC, Carcaño-Díaz K, Ortega-Martínez M, Jaramillo-Rangel G, García-Juárez J.
PMID: 41304897 [PubMed]


SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer.
Medicina (Kaunas)
Akar H, Ekinci F, Erdo, .
PMID: 41303856 [PubMed - indexed for MEDLINE]


Clinical Management and Prognostic Outcomes of Pancreatic Neuroendocrine Tumors: Insights from a Tertiary Care Center.
Medicina (Kaunas)
Diculescu RI, Stroie T, Istr, Croitoru AE, Gheorghe C, Bra, Dumitra, Eftimie MA, , Poian.
PMID: 41303791 [PubMed - indexed for MEDLINE]


An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.
Int J Mol Sci
Choucair K, Odabashian R, Reddy SN, Azmi AS, Saif MW.
PMID: 41303577 [PubMed - indexed for MEDLINE]


mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)-A Promising Avenue in Cancer Immunotherapy.
Int J Mol Sci
Kabut J, Stopyra M, Nafalska N, St, Miciak M, Jezierza, Furgo, Feret K, Gisterek-Grocholska I.
PMID: 41303473 [PubMed - indexed for MEDLINE]


Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma with Prognostic and Therapeutic Implications.
Int J Mol Sci
Cho D, Shin K, Hong TH, Lee SH, Kim Y, Kim IH, Hong SH, Lee M, Park SJ.
PMID: 41303394 [PubMed - indexed for MEDLINE]


Hypoxia-Induced Extracellular Vesicles and Non-Coding RNAs in Cancer: A Systematic Review of Tumor Dynamics and Therapeutic Implications in Preclinical Animal Models.
Biomedicines
Afonso JPR, Taverna S, Pinsino A, Cammarata G, Andraus RAC, Silva IO, Silva CHM, Oliveira CS, Oliveira RF, Oliveira DAAP, Guedes OA, Maia LP, Junior WRF, Ilias EJ, Uriarte JJ, Insalaco G, Oliveira LVF.
PMID: 41301888 [PubMed]


Pancreatic Metastases from Cervical Squamous Cell Carcinoma: Systematic Review of the Literature and Case Report.
Biomedicines
Qian-Zhang S, Romero-Triana D, Meliga C, Domínguez-Prieto V, López-Botet Zulueta B, Martín-Sánchez M, Jiménez-Galanes S, Rojo-Villardón E, Villarejo-Campos P.
PMID: 41301806 [PubMed]


Shotgun Label-Free Proteomic Analysis for Identification of a Potential Diagnostic Biomarker for Pancreatic Cancer.
Biomedicines
Yamamoto T, Boku S, Mitamura K, Taga A.
PMID: 41301725 [PubMed]


Chemerin and the Gut: From Inflammation to Cancer.
Biomedicines
Pljakic E, Delic E, Corovic I, Maksic M, Radojevic D, Stanisavljevic I, Mladenovic V, Nikolic T, Suljic L, Licina EC, Vucelj S, Sagdati S, Corovic K, Igrutinovic N, Urakovic N, Plojovic H, Habibovic S, Habibovic A, Popovic D, Nikolic M, Jovanovic M.
PMID: 41301712 [PubMed]


Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components.
Cancers (Basel)
De Lucia SS, Nista EC, Candelli M, Archilei S, Deutschbein F, Capuano E, Gasbarrini A, Franceschi F, Pignataro G.
PMID: 41300985 [PubMed]


Impact of Dosimetric Parameters on Tumor Control in Stereotactic Radiotherapy for Pancreatic Cancer: A Prospective Study on 104 Patients Treated with Simultaneous Integrated Protection (SIP).
Cancers (Basel)
Bonù ML, Balduzzi J, Pedersoli G, Moneghini D, Ramera M, Portolani N, Andreuccetti J, Grazioli L, Frittoli B, Molfino S, Bozzola AM, Cefaratti MT, Mataj E, Volpi G, Spiazzi L, Saiani F, Fiume A, Tomasi C, Morelli V, Vitali P, Frassine F, Triggiani L, Guerini A, Tomasini D, Terraneo F, Della Casa D, Barbera F, Magrini SM, Buglione M.
PMID: 41300984 [PubMed]


Association of chemotherapy and stoma features with peristomal skin disorders in rectal cancer patients.
Sci Rep
Shiraishi T, Nishizawa Y, Nakajima M, Kado R, Ogawa H, Naomi S, Owada Y, Enomoto T, Yazawa S, Hamahata Y, Isogami Y, Kitagawa K, Sakamoto M, Enomoto H, Egawa A, Kitaguchi D, Hasegawa H, Ikeda K, Tsukada Y, Ito M.
PMID: 41298770 [PubMed - indexed for MEDLINE]


A autophagy related gene signature to predict the prognosis of pancreatic carcinoma and tumor immune microenvironment evaluation.
Sci Rep
Wang X, Wang X, Ying B.
PMID: 41298756 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 58267    Page 1 de 2914  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1